ARCHIVES

NCI Cooperative Group, Cancer Center Trials Listed

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial

March 28, 2014

PDQ Evaluation to Cost NCI More Than Reported

June 29, 1990

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

May 25, 2001

New NCI Directory

May 19, 1989

Pesticides Not A Risk Factor For Long Island Breast Cancer, Study Finds

September 6, 2002

Swedish Study Finds Long Term Hormonal Therapy May Increase Breast Cancer Risk

August 4, 1989